Hydrochloric Acid

Hydrochloric Acid

SCHEMBL321031

CCCCCCCCCCCCCCCCCCC(N)CCCCCCCCCCCCCCCCCC.Cl

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 known ✓ O95136 5/20 0.59
S1PR1 known ✓ P21453 5/20 0.59
S1PR3 known ✓ Q99500 5/20 0.59
S1PR4 known ✓ O95977 4/20 0.59
OPRM1 known ✓ P35372 1/20 0.57
PLA2G1B P04054 1/20 0.60
PLA2G2A P14555 1/20 0.60
SPHK1 Q9NYA1 2/20 0.52
ALDH1A1 P00352 1/20 0.50
CYP2D6 P10635 2/20 0.48
GMNN O75496 1/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
THPO P40225 1/20 0.48
MTOR P42345 1/20 0.48
BLM P54132 1/20 0.48
KDM4E B2RXH2 1/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29131326 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL9133431 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL3837898 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL28525593 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL565333 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL5547432 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL23496017 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL2698937 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL5547447 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3
Hydrochloric Acid SCHEMBL10422267 1.00 PLA2G1B (0.60) PLA2G1BPLA2G2AS1PR2S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4749337-A1 METHOD FOR PRODUCING CHOLESTERIC LIQUID CRYSTAL LAYER, CHOLESTERIC LIQUID CRYSTAL LAYER, REFLECTIVE FILM, LAMINATED GLASS, HEAD-UP DISPLAY SYSTEM, AND COMPOSITION FUJIFILM Corporation (JP) 2026-05-27 EP disclosed
US-12638709-B2 Liquid crystal diffraction element, optical element, image display unit, head-mounted display, beam steering, and sensor FUJIFILM CORPORATION (JP) 2026-05-26 US disclosed
US-20260140287-A1 LIQUID CRYSTAL COMPOSITION, OPTICAL ABSORPTION ANISOTROPIC FILM, METHOD OF PRODUCING OPTICAL ABSORPTION ANISOTROPIC FILM, OPTICAL LAMINATE, AND IMAGE DISPLAY APPARATUS FUJIFILM CORPORATION (JP) 2026-05-21 US disclosed
WO-2026105743-A1 POLARIZATION INTERFERENCE ELEMENT, OPTICAL FILTER, AND OPTICAL SYSTEM 富士フイルム株式会社 2026-05-21 WO disclosed
US-20260142380-A1 LIQUID CRYSTAL COMPOSITION FOR RADIO WAVE CONTROL ELEMENT, AND RADIO WAVE CONTROL ELEMENT FUJIFILM CORPORATION (JP) 2026-05-21 US disclosed
EP-4745633-A1 LIQUID CRYSTAL COMPOSITION, OPTICALLY ANISOTROPIC LAYER, CURED FILM, DIFFRACTION ELEMENT, AND COMPOUND FUJIFILM Corporation (JP) 2026-05-20 EP disclosed
EP-4745164-A1 COMPOSITION, OPTICALLY ANISOTROPIC LAYER, CURED FILM, AND DIFFRACTION ELEMENT FUJIFILM Corporation (JP) 2026-05-20 EP disclosed
US-20260133385-A1 OPTICAL COMMUNICATION DEVICE FUJIFILM CORPORATION (JP) 2026-05-14 US disclosed
US-20260126577-A1 POLARIZING PLATE AND DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2026-05-07 US disclosed
US-12619019-B2 Composition for forming polarizer, polarizer, laminate, and image display device FUJIFILM CORPORATION (JP) 2026-05-05 US disclosed
US-5919983-A COMPRISING A CATION WHICH IS A BRONSTED ACID CAPABLE OF DONATING A PROTON AND AN INERT, COMPATIBLE, NONCOORDINATING ANION THE DOW CHEMICAL COMPANY (US) 1999-07-06 US disclosed
EP-0926533-A2 Optical compensating sheet and liquid crystal display comprising the sheet Fuji Photo Film Co., Ltd. (JP) 1999-06-30 EP disclosed
EP-0911656-A2 Optical compensatory sheet and liquid crystal display FUJI PHOTO FILM CO., LTD. (JP) 1999-04-28 EP disclosed
EP-0864906-A1 Liquid crystal display and optical compensatory sheet FUJI PHOTO FILM CO., LTD. (JP) 1998-09-16 EP disclosed
EP-0841065-A2 Use of sericin as antioxidants and tyrosinase inhibitors SEIREN CO., LTD. (JP) 1998-05-13 EP disclosed
EP-0461827-B1 Hair restorer HAYASHIBARA BIOCHEM LAB (JP) 1997-09-17 EP disclosed
EP-0461827-A2 Hair restorer KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 1991-12-18 EP disclosed
EP-0100644-B2 SHAMPOO COMPOSITIONS AND METHOD OF CLEANING HAIR THEREWITH THE PROCTER & GAMBLE COMPANY (US) 1990-10-24 EP disclosed
EP-0100644-B1 SHAMPOO COMPOSITIONS AND METHOD OF CLEANING HAIR THEREWITH THE PROCTER & GAMBLE COMPANY (US) 1987-04-29 EP disclosed
US-4373073-A Process for the preparation of glycidyl ethers of monohydric or polyhydric phenols, the glycidyl ethers and use thereof HOECHST AKTIENGESELLSCHAFT (DE) 1983-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260140287-A1 LIQUID CRYSTAL COMPOSITION, OPTICAL ABSORPTION ANISOTROPIC FILM, METHOD OF PRODUCING OPTICAL ABSORPTION ANISOTROPIC FILM, OPTICAL LAMINATE, AND IMAGE DISPLAY APPARATUS STRA6, RCC1, CA1 S1PR2 2048/4885S1PR1 1367/4885S1PR3 1899/4885
US-20260126577-A1 POLARIZING PLATE AND DISPLAY DEVICE DCX, DSP, ITGA4 S1PR2 3715/4885S1PR1 3886/4885S1PR3 3767/4885
US-20260142380-A1 LIQUID CRYSTAL COMPOSITION FOR RADIO WAVE CONTROL ELEMENT, AND RADIO WAVE CONTROL ELEMENT CRY1, RAD1, CRYAA S1PR2 4306/4885S1PR1 4212/4885S1PR3 4541/4885
US-20260133385-A1 OPTICAL COMMUNICATION DEVICE CRY1, CDH1, CRY2 S1PR2 3229/4885S1PR1 3551/4885S1PR3 3400/4885
US-12619019-B2 Composition for forming polarizer, polarizer, laminate, and image display device HBS1L, RCC1, SLTM S1PR2 2371/4885S1PR1 2079/4885S1PR3 1465/4885
US-12638709-B2 Liquid crystal diffraction element, optical element, image display unit, head-mounted display, beam steering, and sensor ZKSCAN2, UACA, OCIAD1 S1PR2 2050/4885S1PR1 2509/4885S1PR3 2833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.